That would make perfect sense why Gerald wanted the extra billion shares. Through the objective lens, he is following Dr. Rubenfelds lead, and looking down the road towards acquisitions. That summary of Amgen, and your posts have really cleared the picture for me. Lympro might be a near term catalyst for the stock, but it also might provide a long term asset, which can either generate cash flow, or be sold off for the ability to purchase other assets. Amgens acquisition history shows how powerful cash or stock could be when it comes to acquisitions. In a very short time, a company can basically double its assets. Very exciting indeed. I invested for MANF, and this just reinforces that belief.